GLP-1 receptor agonist trials for Obesity

All GLP-1 receptor agonist trials · All Obesity trials

Phase breakdown

Recruiting trials studying GLP-1 receptor agonist for Obesity

• Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy
  NCT06903923 · Phase: Phase 2 · Ages: 12 Years to 21 Years · Sex: All (male and female) · 1 location
• Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
  NCT07309094 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Impact GLP-1 Agonists Following Bariatric
  NCT06132477 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials study GLP-1 receptor agonist for Obesity?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.